ArticleFrontiers in cardiovascular medicine2024

One-year real-world experience with mavacamten and its physiologic effects on obstructive hypertrophic cardiomyopathy.

Daniel Seung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.